New publication in Nature Immunology dissecting the mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 COVID-19 vaccine.

Our perspective in Current Opinion in Immunology on using adjuvants to program the innate immune system via epigenetic mechanisms.

Support from the Wilhelm-Schuler-Foundation